NCT01089439 - Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Acute Chest SyndromeSickle Cell Disease

Interventions

DRUG

Nitric oxide by inhalation INOMAX

"Nitric oxide by inhalation INOMAX 800 ppm~40 ppm during 24 hours then 20 ppm during 24 hours then 10 ppm during 24 hours"

DRUG

Placebo

placebo

Trial Locations (1)

Hoipital Robert Debre, Paris